Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 105.40

-2.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (982)	4/16/1999 5:43:00 PM
From: Troll_29	Read Replies (3) of 3202

I agree it is about SNP's. However the potential for creating value is not in the raw data anyway but in the software and IP that permits manipulation of the data. This is where I understood INCY excels. It is interesting that all recent articles I have seen, omit INCY from the list of bioinformatic companies. Interestingly these same lists all include Celebra. This is impossible to reconcile with reality as I understand it. Is Celebra concentrating on SNP's or is the PE equipment somehow designed to sequence these more rapidly? Where is the threat that scares the big pharmas to the point where they contemplate "a cooperative effort."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next